Psychosocial distress at diagnosis and 12 months later

Every prostate cancer patient (and many patients subsequently found not to have prostate cancer) have been through the psychological and social distress associated with the risk of a diagnosis of prostate cancer. It’s no fun. … READ MORE …

Predicting risk for Gleason score upgrades in non-surgical patients

The ability to predict risk for Gleason score upgrading in patients who have any form of treatment other than radical prostatectomy can be important, because it may help treating physicians and their patients to optimize first-line therapy. … READ MORE …

Limited predictive accuracy of endorectal coil MRI

Patients believed to be at potential risk for prostate cancer that may extend outside the prostate itself — through extracapsular extension (ECE) or seminal vesicle invasion (SVI) — often undergo imaging studies in planning for their treatment. Endorectal coil magnetic resonance imaging (erMRI) as been a commonly used form of such imaging. … READ MORE …

Can the presence of hyaluronidase predict risk for progression?

A key goal of the prostate cancer research community has been the identification of markers that could help us to better identify patients at high risk for prostate cancer progression as early as possible in the disease process. It now appears that the presence of an enzyme called HYAL-1 hyaluronidase and hyaluronic acid staining in prostatectomy specimens may be able to do this. … READ MORE …

The news report: Wednesday, April 15, 2009

Today’s reports deal with:

  • Prediction of positive lymph pelvic nodes in newly diagnosed patients
  • Active surveillance: current criteria for management and outcomes overview
  • Metabolic complications of androgen deprivation therapy … READ MORE …

The Wednesday news report: March 25, 2009

We have separately addressed data from a 15-year follow-up of a population-based Swedish screening study. Other reports today deal with:

  • The impact of dietary and supplemental zinc on prostate cancer risk
  • Prediction of risk for loss/preservation of erectile function post- prostatectomy
  • Anti-androgen therapy and brachytherapy: options and outcomes … READ MORE ….

The accuracy of the the Kattan prostate nomogram prognostic data

Many clinicians and their patients use the so-called Kattan nomograms to help make decisions about outcomes following use of certain types of prostate cancer treatment. Apparently these prediction tools have also become known in at least some circles as “Prostagram” data. (This is the first time The “New” Prostate Cancer InfoLink has ever come across the use of this term.) … READ MORE …